Barclays provides a summary of rating and estimate changes for Americas Small Cap stocks as of May 13, 2026, highlighted by a downgrade of Pet Valu and price target adjustments for several biotech and energy firms.
Key Takeaways
- 1.Barclays downgraded Pet Valu Holdings Ltd. (PET.TO) to Equal Weight from Overweight, citing heightened operational risk in an uncertain macro backdrop after a 1Q26 EPS miss.
- 2.Price targets were raised for several healthcare and energy companies, including AnaptysBio ($75 from $63) and National Energy Services Reunited Corp ($35 from $34).
- 3.Under Armour (UAA) and ZoomInfo (GTM) both saw price target cuts to $5.00 following weak guidance or strategic shifts.
Table of Contents
- Summary of Changes
- Company Research
- Publications Summary
- Consumer
- Energy
- Healthcare
- Internet & Media
- Retail
- Technology
- Analyst(s) Certification(s)
- Important Disclosures
Document Preview
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Andrew LazarJ. David Anderson, CFAEtzer Darout, PhD, MBAAdrienne Yih
Securities
PET.TOANABNESRUAA
Themes
Macroeconomic Headwinds in Consumer SectorsBiotechnology Clinical and Regulatory Catalysts
Regions
North AmericaUnited StatesCanada